Bisphosphonates in the prevention of bone metastases: Current evidence

被引:30
作者
Diel, IJ [1 ]
机构
[1] Heidelberg Univ, Dept Obstet & Gynaecol, D-6900 Heidelberg, Germany
关键词
D O I
10.1053/sonc.2001.25429
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:75 / 80
页数:6
相关论文
共 28 条
  • [1] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
    Berenson, JR
    Lichtenstein, A
    Porter, L
    Dimopoulos, MA
    Bordoni, R
    George, S
    Lipton, A
    Keller, A
    Ballester, O
    Kovacs, MJ
    Blacklock, HA
    Bell, R
    Simeone, J
    Reitsma, DJ
    Heffernan, M
    Seaman, J
    Knight, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 488 - 493
  • [2] Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events
    Berenson, JR
    Lichtenstein, A
    Porter, L
    Dimopoulos, MA
    Bordoni, R
    George, S
    Lipton, A
    Keller, A
    Ballester, O
    Kovacs, M
    Blacklock, H
    Bell, R
    Simeone, JF
    Reitsma, DJ
    Heffernan, M
    Seaman, J
    Knight, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 593 - 602
  • [3] Current use of bisphosphonates in oncology
    Body, JJ
    Bartl, R
    Burckhardt, P
    Delmas, PD
    Diel, IJ
    Fleisch, H
    Kanis, JA
    Kyle, RA
    Mundy, GR
    Paterson, AHG
    Rubens, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3890 - 3899
  • [4] Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO
  • [5] 2-Z
  • [6] DETECTION OF TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER - A PROGNOSTIC FACTOR FOR DISTANT METASTASIS
    DIEL, IJ
    KAUFMANN, M
    GOERNER, R
    COSTA, SD
    KAUL, S
    BASTERT, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) : 1534 - 1539
  • [7] Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate
    Diel, IJ
    Lichinitser, MR
    Body, JJ
    Schlosser, K
    Moecks, J
    Cavalli, F
    Dornoff, W
    Gorbunova, VA
    McCloskey, E
    Weiss, J
    Kanis, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S83 - S83
  • [8] Reduction in new metastases in breast cancer with adjuvant clodronate treatment
    Diel, IJ
    Solomayer, EF
    Costa, SD
    Gollan, C
    Goerner, R
    Wallwiener, D
    Kaufmann, M
    Bastert, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) : 357 - 363
  • [9] Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal
    Diel, IJ
    Kaufmann, M
    Costa, SD
    Holle, R
    vonMinckwitz, G
    Solomayer, EF
    Kaul, S
    Bastert, G
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (22): : 1652 - 1658
  • [10] Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
    Diel, IJ
    Cote, RJ
    [J]. CANCER TREATMENT REVIEWS, 2000, 26 (01) : 53 - 65